Compounding Pharmacy Market worth $21.01 billion by 2031
The report "Compounding Pharmacy Market by Product (Oral, Topical, Parenteral), Type (Ingredient Alteration, Dosage Alteration), Therapeutic Application (Pain Management, HRT, Dermatology), Sterility (Sterile), End User, Competition, Region - Global Forecast to 2031", is projected to grow from USD 15.48 billion in 2026 and to reach USD 21.01 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period.
Browse 480 market data Tables and 60 Figures spread through 350 Pages and in-depth TOC on "Compounding Pharmacy Market by Product (Oral, Topical, Parenteral), Type (Ingredient Alteration, Dosage Alteration), Therapeutic Application (Pain Management, HRT, Dermatology), Sterility (Sterile), End User, Competition, Region - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/compounding-pharmacy-market-57885999.html
By compounding type, the pharmaceutical dosage alteration segment accounted for the largest share of the compounding pharmacy market in 2025.
By compounding type, the global compounding pharmacy market is divided into pharmaceutical dosage alteration, pharmaceutical ingredient alteration, and currently unavailable pharmaceutical manufacturing. In 2025, the pharmaceutical dosage alteration segment held the largest share of the compounding pharmacy market, driven by growing demand for patient-specific medication strengths and dosage forms. Dosage alteration enables pharmacists to modify drug concentrations to meet individual therapeutic requirements, particularly for pediatric & geriatric patients and those with swallowing difficulties. Increasing adoption of personalized medicine, combined with advances in precision compounding techniques and stringent quality standards, further supports the segment’s growth.
By therapeutic application, the hormone replacement therapy segment will be the fastest-growing market from 2026 to 2031.
By therapeutic application, hormone replacement therapy (HRT) is emerging as the fastest-growing segment in the compounding pharmacy market, driven by increasing awareness of personalized treatment options for hormonal imbalances and age-related conditions. Compounded HRT allows customization of hormone type, dosage, and delivery method, such as creams, gels, troches, or injections, tailored to individual patient needs, enhancing efficacy and minimizing side effects compared to standard commercially available therapies. The rising prevalence of menopause-related symptoms, andropause, and other endocrine disorders has fueled demand for individualized therapies that address unique hormonal profiles. Advances in formulation technologies, including bioidentical hormones and transdermal delivery systems, have improved absorption, stability, and patient compliance. Expanding access through specialty and retail pharmacies, coupled with ongoing research on long-term efficacy and safety, reinforces hormone replacement therapy’s role as the fastest-growing application in the global compounding pharmacy market.
North America accounted for the largest regional share in the compounding pharmacy market in 2025.
The compounding pharmacy market is divided into five segments: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2025, North America held the largest share of the global compounding pharmacy market, supported by well-established healthcare infrastructure, high demand for personalized medications, and the strong presence of specialized compounding pharmacies. The US drives regional growth through widespread adoption of customized dosage forms, including sterile preparations, hormone replacement therapies, and topical medications. Established regulatory frameworks, particularly FDA and USP standards, further support quality and patient safety. Additionally, increasing prevalence of chronic diseases, an aging population, drug shortages, and growing demand for patient-specific therapies are driving the adoption of compounded medications across hospitals, clinics, and specialty pharmacies.
Key players in the compounding pharmacy market include Baxter (US), Empower Pharmacy (US), B. Braun (Germany), Fagron (Netherlands), and QuVa Pharma (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Compounding Pharmacy Market
- What will your New Revenue Sources be
- Who will be your Top Customer; what will make them switch
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
